Paper34278671
Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*.
Su X and 7 others. Angew Chem Int Ed Engl, 2021. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*. Papers, record 34278671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34278671
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Endoribonucleases | Major topic |
| Enzyme Activation | Major topic |
| Oligonucleotides, Antisense | Major topic |
| SARS-CoV-2 | Major topic |
| Animals | |
| Chlorocebus aethiops | |
| Coronavirus Envelope Proteins | |
| Drug Design | |
| HEK293 Cells | |
| Humans | |
| Hydrolysis | |
| Microbial Sensitivity Tests | |
| Mutation | |
| RNA, Viral | |
| Spike Glycoprotein, Coronavirus | |
| Vero Cells |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 21877001 | National Natural Science Foundation of China | PubMed | ||
| 22077005 | National Natural Science Foundation of China | PubMed | ||
| 81821004 | National Natural Science Foundation of China | PubMed | ||
| 2017ZX09303013 | Ministry of Science and Technology of the People's Republic of China | PubMed |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31494033 | Concerted 2-5A-Mediated mRNA Decay and Transcription Reprogram Protein Synthesis in the dsRNA Response. | Mol Cell | 2019 | https://conductscience.org/library/papers/31494033 | PubMed |
| 2 | 31964809 | Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/31964809 | PubMed |
| 3 | 27097021 | Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs. | ACS Chem Biol | 2016 | https://conductscience.org/library/papers/27097021 | PubMed |
| 4 | 28484023 | Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28484023 | PubMed |
| 5 | 22704621 | Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. | Cell Host Microbe | 2012 | https://conductscience.org/library/papers/22704621 | PubMed |
| 6 | 33762737 | Antisense technology: an overview and prospectus. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33762737 | PubMed |
| 7 | 34278671 | Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*. | Angew Chem Int Ed Engl | 2021 | https://conductscience.org/library/papers/34278671 | PubMed |
| 8 | 28808124 | Rapid RNase L-driven arrest of protein synthesis in the dsRNA response without degradation of translation machinery. | RNA | 2017 | https://conductscience.org/library/papers/28808124 | PubMed |
| 9 | 9050883 | Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9050883 | PubMed |
| 10 | 31130520 | Targeted Degradation of a Hypoxia-Associated Non-coding RNA Enhances the Selectivity of a Small Molecule Interacting with RNA. | Cell Chem Biol | 2019 | https://conductscience.org/library/papers/31130520 | PubMed |
| 11 | 7679499 | Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/7679499 | PubMed |
| 12 | 32295917 | RNase L Amplifies Interferon Signaling by Inducing Protein Kinase R-Mediated Antiviral Stress Granules. | J Virol | 2020 | https://conductscience.org/library/papers/32295917 | PubMed |
| 13 | 23084743 | Innate immune messenger 2-5A tethers human RNase L into active high-order complexes. | Cell Rep | 2012 | https://conductscience.org/library/papers/23084743 | PubMed |
| 14 | 32782413 | Advances in oligonucleotide drug delivery. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/32782413 | PubMed |
| 15 | 30004000 | PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy. | J Control Release | 2018 | https://conductscience.org/library/papers/30004000 | PubMed |
| 16 | 30467074 | Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis. | J Cyst Fibros | 2019 | https://conductscience.org/library/papers/30467074 | PubMed |
| 17 | 32648313 | Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection. | Rev Med Virol | 2020 | https://conductscience.org/library/papers/32648313 | PubMed |
| 18 | 31494035 | RNase L Reprograms Translation by Widespread mRNA Turnover Escaped by Antiviral mRNAs. | Mol Cell | 2019 | https://conductscience.org/library/papers/31494035 | PubMed |
| 19 | 32104389 | Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery. | Asian J Pharm Sci | 2018 | https://conductscience.org/library/papers/32104389 | PubMed |
| 20 | 33140033 | Targeting the SARS-CoV-2 RNA Genome with Small Molecule Binders and Ribonuclease Targeting Chimera (RIBOTAC) Degraders. | ACS Cent Sci | 2020 | https://conductscience.org/library/papers/33140033 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42239496 | Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42239496 | PubMed |
| 42171504 | Extending the Targets for Coronavirus Antivirals Beyond That of Approved Drugs: Insights From Preclinical Research. | Microb Biotechnol | 2026 | https://conductscience.org/library/papers/42171504 | PubMed |
| 41596370 | Application of Orthoflavivirus Pseudovirus Technology in Antiviral Research. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596370 | PubMed |
| 41130951 | DNA computing function switching by programming base stacking interactions with minimal molecular architecture changes. | Nat Commun | 2025 | https://conductscience.org/library/papers/41130951 | PubMed |
| 41042259 | PROteolysis TArgeting Chimeras (PROTACs) and beyond: targeted degradation as a new path to fight microbial pathogens. | FEMS Microbiol Rev | 2025 | https://conductscience.org/library/papers/41042259 | PubMed |
| 40686860 | Antisense oligonucleotides targeting the SARS-CoV-2 nucleocapsid gene decrease viral titers in hamsters. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/40686860 | PubMed |
| 40427100 | Long Non-Coding RNAs and RNA-Binding Proteins in Pancreatic Cancer Development and Progression. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40427100 | PubMed |
| 39990950 | Nucleic Acid Conjugates: Unlocking Therapeutic Potential. | ACS Bio Med Chem Au | 2025 | https://conductscience.org/library/papers/39990950 | PubMed |
| 39779694 | Chemical-guided SHAPE sequencing (cgSHAPE-seq) informs the binding site of RNA-degrading chimeras targeting SARS-CoV-2 5' untranslated region. | Nat Commun | 2025 | https://conductscience.org/library/papers/39779694 | PubMed |
| 39727035 | The Unusual Role of Ribonuclease L in Innate Immunity. | Wiley Interdiscip Rev RNA | 2024 | https://conductscience.org/library/papers/39727035 | PubMed |
| 39630134 | Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition. | RNA Biol | 2024 | https://conductscience.org/library/papers/39630134 | PubMed |
| 38641489 | Heterobifunctional small molecules to modulate RNA function. | Trends Pharmacol Sci | 2024 | https://conductscience.org/library/papers/38641489 | PubMed |
| 38598625 | Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera. | Sci Adv | 2024 | https://conductscience.org/library/papers/38598625 | PubMed |
| 37066172 | Chemical-guided SHAPE sequencing (cgSHAPE-seq) informs the binding site of RNA-degrading chimeras targeting SARS-CoV-2 5' untranslated region. | bioRxiv | 2023 | https://conductscience.org/library/papers/37066172 | PubMed |
| 36735698 | Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection. | PLoS One | 2023 | https://conductscience.org/library/papers/36735698 | PubMed |
| 36714073 | Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection. | Cell Rep Phys Sci | 2023 | https://conductscience.org/library/papers/36714073 | PubMed |
| 36675069 | DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675069 | PubMed |
| 36674746 | Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36674746 | PubMed |
| 36551374 | A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36551374 | PubMed |
| 36139095 | Recent Advances of Degradation Technologies Based on PROTAC Mechanism. | Biomolecules | 2022 | https://conductscience.org/library/papers/36139095 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RNASEL | 6041 | PubTator's text mining | https://conductscience.org/library/genes/6041 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34278671
GET https://conductscience.org/api/papers/v1/34278671/references?page=2